Table 2.
Trial, Year | Number of Pts | Technology | Control 12 Month NSR |
Treated 12 Month NSR |
---|---|---|---|---|
Deneke et al., 2002 | 30 | Unipolar Cooled RF | 26.7% | 80% (p < 0.01) |
Schuetz et al., 2003 | 43 | Microwave | 33.3% | 80% (p = 0.036) |
Akpinar et al., 2003 | 67 | Unipolar RF | 9.4% | 93.6% (p = 0.0001) |
Abreu Filho et al., 2005 | 70 | Unipolar Cooled RF | 26.9% | 79.4% (p = 0.001) |
Doukas et al., 2005 | 101 | Unipolar RF | 4.5% | 44.4% (p = 0.001) |
Blomström-Lunqvist 2007 | 69 | Cryoablation | 42.9% | 73.3% (p = 0.013) |
Chevalier 2009 |
43 | Unipolar RF | 4% | 57% (p = 0.004) |
Gillinov, 2015 | 260 | Cryoablation | 29% | 63.2% (p < 0.001) |